VYRIPHARM Trademark Information

Trademark by Vyripharm Enterprises LLC

Pharmaceutical drugs for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; pharmaceutical products for treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; diagnostic preparations, namely, drugs for neurological disorders, cancer oncology, diabetes, metabolic disease for medical purposes; drug devices, namely, injectable intravenous and subcutaneous drug delivery devices filled...

Drug delivery systems, namely, gel patch or patch delivery system sold without medication, implantable drug delivery pumps, and drug delivery catheters

Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical products development and testing of pharmaceuticals- accepted as written; Compiling of data related to diagnostic and pharmaceutical drugs and raw materials for pharmaceutical drug development purposes

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (010)
Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 9/28/2014
First Use In Commerce: 9/28/2014
General Information
Word mark: VYRIPHARM
Status/Status Date:
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
3/20/2022
Estimated Response Deadline: 9/20/2022
Serial Number: 90474434
Filing Date: 1/19/2021
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical drugs for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; pharmaceutical products for treatment of neurological disorders, cancer oncology, diabetes, metabolic disease; diagnostic preparations, namely, drugs for neurological disorders, cancer oncology, diabetes, metabolic disease for medical purposes; drug devices, namely, injectable intravenous and subcutaneous drug delivery devices filled with pharmaceutical drugs and drug preparations for neurological disorders, cancer oncology, diabetes, metabolic disease; drug delivery system comprising of patch and adhesive biodegradable membrane externally or internally that facilitate the delivery of a wide range of pharmaceuticals for the treatment of neurological disorders, cancer oncology, diabetes, metabolic disease and infectious diseases
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: N/A
Last Applicant/Owner:
Vyripharm Enterprises LLC
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
NON-FINAL OFFICE ACTION ISSUED - CLARIFICATION NEEDED
3/20/2022
Correspondent Search:
Tasha Snipes is a correspondent of VYRIPHARM trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on